Table 3. Survivorship based on the... | American Society of Hematology

Table 3.

Survivorship based on the classification and regression tree–selected cutoff values used to designate patients with multiple myeloma as high or low CD19⁺ patients at baseline and the 2-year time point

CD19 levels^3-150	Baseline^3-151	2 year^3-151
Low CD19	2.8	2.2
High CD19	4.0	4.4
P	< .0001	< .0001

MM indicates multiple myeloma.

F3-150

Patients with MM were subdivided into low or high CD19 subgroups based on their level of CD19⁺ cells being below or above the CART-detemined levels. The levels were determined separately for each patient with MM at baseline (N = 504) and at 2-year time point (N = 173).

F3-151

Data is presented as survival in years from the time of CD19 cell.

View Large

This Feature Is Available To Subscribers Only